PWS
AUPH icon

Precision Wealth Strategies’s Aurinia Pharmaceuticals AUPH Stock Holding History

Precision Wealth Strategies’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
+71,014
New +$1.13M 0.36% 63
2026
Q1 		– Sell
-54,176
Closed -$864K – 161
2025
Q4 		$864K Sell
54,176
-7,866
-13% -$112K 0.28% 79
2025
Q3 		$686K Buy
+62,042
New +$678K 0.22% 100

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Precision Wealth Strategies's AUPH Position: Q2 2026 in Review

Precision Wealth Strategies opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 71,014 shares worth $1.21M. The stake represents 0.36% of the portfolio and ranks #63 among its holdings. This is a return to the name: Precision Wealth Strategies previously reported a position in AUPH as recently as Q4 2025.

Precision Wealth Strategies first reported a position in AUPH in Q3 2025 and has held it in 3 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Precision Wealth Strategies held 71,014 shares of Aurinia Pharmaceuticals worth $1.21M as of Q2 2026.
  • Aurinia Pharmaceuticals was a new Precision Wealth Strategies position in Q2 2026.
  • Aurinia Pharmaceuticals made up 0.36% of Precision Wealth Strategies's portfolio in Q2 2026, its #63 holding.
  • Precision Wealth Strategies first reported a position in Aurinia Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Precision Wealth Strategies's 13F filing for Q2 2026, filed 10 Aug 2026.